References
- Clyman RI, Mauray F, Roman C, Rudolph AM, Heymann MA. Circulating prostaglandin E2 concentrations and patent ductus arteriosus in fetal and neonatal lambs. J Pediatr 1980;97:455–461.
- Shannon E.G., Hamrick and Georg Hansmann. Patent Ductus Arteriosus of the Preterm Infant. Pediatrics 2010;125:1020–1030.
- The Investigators of the Vermont-Oxford Trials Network Database Project. The Vermont-Oxford Trials Network: Very Low Birth Weight Outcomes for 1990. Pediatrics 1993;91:540–545.
- Talner NS. The physiology of congenital heart disease. In: The Science and Practice of Pediatric Cardiology, 2nd, Garson A, Bricker TJ, Fisher DJ, Neish SR (Eds), Williams and Wilkins, Baltimore 1998.
- Reiner Buchhorn, Annette Hammersen, Dietmar Bartmus and Joachim Bürsch. The pathogenesis of heart failure in infants with congenital heart disease. Cardiology in the Young 2001;11:498–504.
- Attridge JT, Kaufman DA, Lim DS. B-type natriuretic peptide concentrations to guide treatment of patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 2009;94:F178–F182.
- El-Khuffash AF, Slevin M, McNamara PJ, Molloy EJ. Troponin T, N-terminal pro natriuretic peptide and a patent ductus arteriosus scoring system predict death before discharge or neurodevelopmental outcome at 2 years in preterm infants. Arch Dis Child Fetal Neonatal Ed 2011;96:F133–F137.
- Kluckow M, Evans N. Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J Pediatr 2000;137:68–72.
- Petra M. A., Lemmers Mona, C., Toet, and Frank van Bel. Impact of Patent Ductus Arteriosus and Subsequent Therapy With Indomethacin on Cerebral Oxygenation in Preterm Infants. Pediatrics 2008;121:142–147.
- George Cassady, M.D., Dennis T., Crouse, M.D., John W., Kirklin, M.D., et al. A Randomized, Controlled Trial of Very Early Prophylactic Ligation of the Ductus Arteriosus in Babies Who Weighed 1000 g or Less at Birth. N Engl J Med 1989;320:1511–1516.